Carlsbad, CA, United States of America

Naveen Kumar Dakappagari

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations and Contributions of Naveen Kumar Dakappagari

Introduction

Naveen Kumar Dakappagari is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of medical therapies, particularly in the development of innovative treatments for cancer. With a total of six patents to his name, his work focuses on advanced therapeutic methods that target specific biomarkers associated with various diseases.

Latest Patents

Dakappagari's latest patents include groundbreaking therapies such as CD20 therapies, CD22 therapies, and combination therapies utilizing a CD19 chimeric antigen receptor (CAR)-expressing cell. These inventions provide compositions and methods for treating diseases linked to the expression of CD19. The approach involves administering a recombinant T cell that comprises the CD19 CAR, in conjunction with one or more B-cell inhibitors. Additionally, his patents feature novel antigen binding domains and CAR molecules directed to CD20 and CD22, which can be used as monotherapies or in combination therapies. Another notable patent involves a method of scoring a sample containing tumor tissue from cancer patients, which assesses the spatial proximity between cells expressing different biomarkers. This scoring method can indicate the likelihood of a patient responding positively to immunotherapy.

Career Highlights

Throughout his career, Naveen Kumar Dakappagari has worked with esteemed organizations such as Novartis and the University of Pennsylvania. His experience in these institutions has allowed him to collaborate on various innovative projects that advance cancer treatment methodologies.

Collaborations

Some of his notable coworkers include Jennifer Bordeaux and Ju Young Kim. Their collaborative efforts have contributed to the success of the projects they have undertaken together.

Conclusion

Naveen Kumar Dakappagari's contributions to medical innovation, particularly in cancer therapies, highlight his role as a leading inventor in the field. His patents and collaborative work continue to pave the way for advancements in treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…